{{'Search' | translate}}
 

Human Epidermal Growth Factor Recombinant (EGF)

人表皮生长因子重组(EGF)

Company: Biomartcanada
Catalog#: RKP01133
Bio-protocol()
Company-protocol()
Other protocol()

In vitro and in vivo Limiting Dilution Assay for Colorectal Cancer
Author:
Date:
2015-11-20
[Abstract]  The in vitro limiting dilution assay is used to determine the colorectal cancer initiating cell (CC-IC) frequency of a CC-IC enriched suspension culture, grown in growth factor enriched serum free media. The in vivo limiting dilution assay is used to determine the colorectal cancer initiating cell frequency of a primary colorectal cancer sample or an established suspension cell line using immunocompromised murine xenograft models. In vitro and in vivo limiting dilution assays (LDAs) can be used to determine the effect of a specific treatment or genetic knockdown strategy on the initiating cell frequency of a population of CC-ICs or colorectal cancer sample, respectively. [摘要]  体外极限稀释测定法用于测定在富含生长因子的无血清培养基中生长的CC-IC富集悬浮培养物的结肠直肠癌起始细胞(CC-IC)频率。 体内限制性稀释测定法用于使用免疫受损的鼠异种移植物模型确定原发性结肠直肠癌样品或建立的悬浮细胞系的结肠直肠癌起始细胞频率。 可以使用体外和体内有限稀释测定法(LDAs)来确定特定处理或遗传击倒策略对CC- IC或结肠直肠癌样品。

Comments